3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19 Duplicate 1 - CIMIT MAIN

CIMIT is a network of world-class academic and medical institutions partnering with industry and government. Our mission is to foster collaboration among clinicians, technologists, and entrepreneurs to accelerate innovation and catalyze the discovery, development, and implementation of innovative healthcare technologies.

Learn More >

Initiatives and Funding Opportunities

Latest News

null 3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19 Duplicate 1

3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19

The goal is a new, highly accurate, mass-produced low-cost diagnostic device that delivers results in minutes.


ST. PAUL, Minn.--(BUSINESS WIRE)--To help the world respond to COVID-19, 3M and researchers at MIT are testing a new rapid test that detects the virus. Accelerated research is underway to learn if a simple-to-use, diagnostic device can produce highly accurate results within minutes and is feasible to mass manufacture.

The U.S. National Institute of Health selected the rapid COVID-19 test for accelerated development and commercialization support, after rigorous review by an expert panel. The test is in the Rapid Acceleration of Diagnostics Tech (RADx Tech) program, an aggressively-paced COVID-19 diagnostics initiative from the NIH’s National Institute of Biomedical Imaging and Bioengineering.

Read the full release >